Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FAT BRANDS INC. REPORTS FISCAL FOURTH QUARTER AND FULL FISCAL YEAR 2023 FINANCIAL RESULTS
-
Bel Director John Tweedy to Retire from the Board and Not Stand for Re-election at the 2024 Annual Meeting
-
Progress Announces Amended Credit Facility
-
The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results
-
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2023 Results
-
U.S. Global Investors Announces a Substantial Increase in February’s Stock Buybacks Compared to Last Year, Continuation of Monthly Dividends for Past 13 Years
-
Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
MediaAlpha Announces Launch of Secondary Offering
-
Clarus Reports Fourth Quarter and Full Year 2023 Results
-
Quanex Building Products Announces First Quarter 2024 Results and Provides Full Year 2024 Guidance
-
CoreCivic Appoints Catherine Hernandez-Blades and Alexander R. Fischer to its Board of Directors; CoreCivic Also Announces Planned Retirement of Long-Term Board Member Donna Alvarado
-
Jamf announces same-day support for visionOS 1.1
-
Costco Wholesale Corporation Reports Second Quarter and Year-to-Date Operating Results for Fiscal 2024 and February Sales Results
-
HCI Group Reports Fourth Quarter and Full Year 2023 Results
-
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
VALHI REPORTS FOURTH QUARTER 2023 RESULTS
-
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
-
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
-
Gulf Island Reports Fourth Quarter and Full Year 2023 Results
-
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Farmer Brothers Names Terry O’Brien to Board of Directors
-
Enthusiast Gaming Unveils $10 Million Cost Reduction Program
-
Runway Growth Finance Corp. Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results
-
Oil-Dri Achieves Record Results for the Second Quarter and Triples its Net Income
-
Noodles & Company Announces Fourth Quarter and Full Year 2023 Financial Results
-
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
-
Potbelly Corporation Reports Strong Results for Fourth Fiscal Quarter and Full Year 2023
-
El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2023 Financial Results
-
Noodles & Company Announces Appointment of Drew Madsen as CEO
-
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
-
AvidXchange to Participate in Wolfe FinTech Forum 2024
-
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
-
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
-
Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway
-
Concrete Pumping Holdings Reports First Quarter Fiscal Year 2024 Results
-
RadNet Announces Proposed $200 Million Underwritten Public Offering of Common Stock
-
Oxbridge Re Announces 2023 Fourth Quarter Results on March 26, 2024
-
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
-
red violet Announces Fourth Quarter and Full Year 2023 Financial Results
-
Americold Realty Trust, Inc. Declares First Quarter 2024 Dividend
-
Snap One Reports Fiscal Fourth Quarter and Full Year 2023 Results
-
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
-
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
-
ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day
-
HF Foods to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
-
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
-
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Fly Play hf.: Annual General Meeting 21 March 2024 - Final Agenda and Proposals
-
Orthogonal Global Group Announces the Appointment of Mona Coyle to the Board of Directors
